Prof Tom John
Honorary Conjoint Professorial Fellow
The Sir Peter MacCallum Department of Oncology
405 Scholarly works
3 Projects
HIGHLIGHTS
2026
Journal article
First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations
DOI: 10.1056/NEJMoa26044612026
Journal article
Early Detriment Analysis of First-Line Nivolumab plus Ipilimumab-Based Therapy in Patients with Metastatic Non-Small Cell Lung Cancer
DOI: 10.1158/1078-0432.CCR-25-09422026
Journal article
Uneven Ground: Survival Differences Among Victorian Lung Cancer Patients by Location of Residence (2011–2023): A Retrospective Cohort Study
DOI: 10.5694/mja2.702682026
Journal article
Consensus Statement on ctDNA Minimal Residual Disease Testing in Early Stage NSCLC: A Delphi Study by the Asian Thoracic Oncology Research Group
DOI: 10.1016/j.jtho.2026.1036962025
Research grants (ARC, NHMRC, MRFF)
A Registry-Based Randomised Trial of Radiotherapy in Advanced Lung Cancer
2024
Research grants (other domestic)
The Molecular Characterisation of Mesothelioma (Mesogenome Study)
2022
Research grants (other domestic)
A Precision Medicine Program in Mesothelioma
RECENT SCHOLARLY WORKS
2026
Journal article
The ‘power of 1’: The ethics and epistemology of ‘N-of-1 trials’ in oncology
DOI: 10.1177/174701612513514012026
Journal article
Treatment and Survival Outcomes for Indigenous and Non-Indigenous Australians Within the Victorian Lung Cancer Registry: A Retrospective Cross-Sectional Cohort Study
DOI: 10.5694/mja2.702322026
Journal article
Definitive Radiotherapy to the Primary Tumor in Stage IV NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer Advanced Radiation Technology Subcommittee
DOI: 10.1016/j.jtho.2026.1036432026
Journal article
Identifying High-Risk Stage I NSCLC: The Promises and Pitfalls of Tumor-Informed ctDNA
DOI: 10.1016/j.jtho.2026.1037062026
Journal article
Impacts of Multidisciplinary Lung Cancer Meeting Presentation in a Clinical Quality Registry
DOI: 10.1016/j.jtocrr.2026.1009842026
Journal article
Recent Advances in Combined Medical and Surgical Therapy for Resectable NSCLC
DOI: 10.1002/resp.70238